Cargando…
In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System
Sickle Cell Disease (SCD) is an autosomal recessive disorder resulting from a β-globin gene missense mutation and is among the most prevalent severe monogenic disorders worldwide. Haematopoietic stem cell transplantation remains the only curative option for the disease, as most management options fo...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862553/ https://www.ncbi.nlm.nih.gov/pubmed/33553164 http://dx.doi.org/10.3389/fcell.2020.624477 |